Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8414101rdf:typepubmed:Citationlld:pubmed
pubmed-article:8414101lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C0009402lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C1318468lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:8414101lifeskim:mentionsumls-concept:C1548161lld:lifeskim
pubmed-article:8414101pubmed:issue11lld:pubmed
pubmed-article:8414101pubmed:dateCreated1993-11-1lld:pubmed
pubmed-article:8414101pubmed:abstractTextPre-operative skin test response has been evaluated in 50 cases of colorectal carcinoma. Cellular defense's depression was correlated with tumoral staging (p = < 0.001). In B2 and C groups, a higher incidence of metastatic and local recurrences was registered in subjects with low response. These last are suitable for a randomized trial including immunotherapy.lld:pubmed
pubmed-article:8414101pubmed:languageitalld:pubmed
pubmed-article:8414101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8414101pubmed:citationSubsetIMlld:pubmed
pubmed-article:8414101pubmed:statusMEDLINElld:pubmed
pubmed-article:8414101pubmed:monthJunlld:pubmed
pubmed-article:8414101pubmed:issn0026-4733lld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:TestaTTlld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:AccarpioGGlld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:BarbaneraMMlld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:GalganoEElld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:SquillarioEElld:pubmed
pubmed-article:8414101pubmed:authorpubmed-author:BrignoliAAlld:pubmed
pubmed-article:8414101pubmed:issnTypePrintlld:pubmed
pubmed-article:8414101pubmed:day15lld:pubmed
pubmed-article:8414101pubmed:volume48lld:pubmed
pubmed-article:8414101pubmed:ownerNLMlld:pubmed
pubmed-article:8414101pubmed:authorsCompleteYlld:pubmed
pubmed-article:8414101pubmed:pagination613-5lld:pubmed
pubmed-article:8414101pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:meshHeadingpubmed-meshheading:8414101-...lld:pubmed
pubmed-article:8414101pubmed:year1993lld:pubmed
pubmed-article:8414101pubmed:articleTitle[Prognostic significance of cell-mediated immune response in patients with colorectal carcinoma. Preliminary results].lld:pubmed
pubmed-article:8414101pubmed:affiliationII Divisione di Chirurgia, Ospedale Civile, Sampierdarena, Genova.lld:pubmed
pubmed-article:8414101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8414101pubmed:publicationTypeEnglish Abstractlld:pubmed